Clinical Trial

BEGIN Novel ImagiNG Biomarkers

Study acronym: BEGINNING
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To determine the treatment effect of triple-combination therapy in 6-8 year olds after presumed FDA approval, using rapid structural and functional pulmonary and abdominal MRI (UTE and 129Xe).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-08-24; most recent amendment 2024-11-19.
Trial Details
NCT Number NCT05517655
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Collaborators: University of Kansas, University of Iowa, University of Virginia
Conditions Cystic Fibrosis
Enrollment 44 participants
Start Date 2022-05-01
Primary Completion 2028-11-01 (estimated)
Study Completion 2028-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-21